Raisanen, Jack

2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas

Choi, C., Ganji, S. K., DeBerardinis, R. J., Hatanpaa, K. J., Rakheja, D., Kovacs, Z., Yang, X.-L., Mashimo, T., Raisanen, J. M., Marin-Valencia, I., et al. (2012) · Nature Medicine

Glioma Diagnosis and TreatmentAdvanced MRI Techniques and Applications

Cited by 839

Metabolism of [U‐ 13 C]glucose in human brain tumors in vivo

Maher, E. A., Marin‐Valencia, I., Bachoo, R. M., Mashimo, T., Raisanen, J., Hatanpaa, K. J., Jindal, A., Jeffrey, F. M., Choi, C., Madden, C., et al. (2012) · NMR in Biomedicine

Cancer, Hypoxia, and MetabolismGlioma Diagnosis and Treatment

Cited by 341

Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH -Mutant Glioma

Choi, C., Raisanen, J. M., Ganji, S. K., Zhang, S., McNeil, S. S., An, Z., Madan, A., Hatanpaa, K. J., Vemireddy, V., Sheppard, C. A., et al. (2016) · Journal of Clinical Oncology

Glioma Diagnosis and TreatmentAdvanced MRI Techniques and Applications

Cited by 201

Neuroanatomic Profile of Polyglutamine Immunoreactivity in Huntington Disease Brains

Herndon, E. S., Hladik, C. L., Shang, P., Burns, D. K., Raisanen, J., & White, C. L. (2009) · Journal of Neuropathology & Experimental Neurology

Genetic Neurodegenerative DiseasesNeurological diseases and metabolism

Cited by 57

Microenhancement as a Biomarker for Cerebral Microbleed in Inflammatory Cerebral Amyloid Angiopathy: Insights From 3D T1 Black-Blood MR Imaging

Shang, T., Sguigna, P. V., Pinho, M. C., Moore, W., Jones, E., Subramanian, S., Upadhyaya, P., Kelley, B., Hatanpaa, K. J., & Raisanen, J. (2025) · Neurology

Intracerebral and Subarachnoid Hemorrhage ResearchCerebrovascular and genetic disorders

Cited by 3